Incidence of venous thromboembolism in hospitalized patients with COVID-19

Incidence of venous thromboembolism in hospitalized patients with COVID-19

1 May 2020 | Saskia Middeldorp, Michiel Coppens, Thijs F. van Haaps, Merijn Foppen, Alexander P. Vlaar, Marcella C. A. Müller, Catherine C. S. Bouman, Ludo F. M. Beenen, Ruud S. Kootte, Jarom Heijmans, Loek P. Smits, Peter I. Bonta, Nick van Es
The COVID-19 Resource Centre, established by Elsevier in January 2020, provides free information in English and Mandarin on the novel coronavirus. Elsevier grants permission to make all COVID-19-related research available in PubMed Central and other public repositories, with unrestricted reuse and analysis rights, as long as the resource centre remains active. A single-center cohort study of 198 hospitalized patients with COVID-19 was conducted to investigate the incidence of objectively confirmed venous thromboembolism (VTE). The study found that 20% of patients were diagnosed with VTE, with 13% experiencing symptomatic VTE despite routine thrombosis prophylaxis. The cumulative incidence of VTE at 7, 14, and 21 days was 16%, 33%, and 42%, respectively. ICU patients had a higher risk of VTE compared to ward patients, with a cumulative incidence of 26%, 47%, and 59% at 7, 14, and 21 days, respectively. VTE was significantly associated with mortality, with an adjusted hazard ratio of 2.4. The study highlights the high risk of VTE in COVID-19 patients, particularly in ICU patients, and emphasizes the need for high clinical suspicion and low-threshold diagnostic imaging for DVT or PE. Future research should focus on optimal diagnostic and prophylactic strategies to prevent VTE and potentially improve survival.The COVID-19 Resource Centre, established by Elsevier in January 2020, provides free information in English and Mandarin on the novel coronavirus. Elsevier grants permission to make all COVID-19-related research available in PubMed Central and other public repositories, with unrestricted reuse and analysis rights, as long as the resource centre remains active. A single-center cohort study of 198 hospitalized patients with COVID-19 was conducted to investigate the incidence of objectively confirmed venous thromboembolism (VTE). The study found that 20% of patients were diagnosed with VTE, with 13% experiencing symptomatic VTE despite routine thrombosis prophylaxis. The cumulative incidence of VTE at 7, 14, and 21 days was 16%, 33%, and 42%, respectively. ICU patients had a higher risk of VTE compared to ward patients, with a cumulative incidence of 26%, 47%, and 59% at 7, 14, and 21 days, respectively. VTE was significantly associated with mortality, with an adjusted hazard ratio of 2.4. The study highlights the high risk of VTE in COVID-19 patients, particularly in ICU patients, and emphasizes the need for high clinical suspicion and low-threshold diagnostic imaging for DVT or PE. Future research should focus on optimal diagnostic and prophylactic strategies to prevent VTE and potentially improve survival.
Reach us at info@study.space